Esclerose Múltipla: associação do estado nutricional e qualidade de vida

Mayara Pereira da Silva Morais; Beatriz Melo de Carvalho; Renan Souto Pereira; Larissa Lara de Sousa Avelino; José Artur Costa D’Almeida; Maria Luisa Pereira de Melo

doi:10.52521/nutrivisa.v12i1.14552

Authors

Mayara Pereira da Silva Morais Curso de Nutrição, Universidade Estadual do Ceará, Fortaleza, CE, Brasil https://orcid.org/0009-0006-9216-0176
Beatriz Melo de Carvalho Programa de Pós-Graduação em Nutrição e Saúde (PPGNS), Universidade Estadual do Ceará, Fortaleza, CE, Brasil https://orcid.org/0000-0002-3084-5616
Renan Souto Pereira Programa de Pós-Graduação em Nutrição e Saúde (PPGNS), Universidade Estadual do Ceará, Fortaleza, CE, Brasil https://orcid.org/0000-0002-7116-6329
Larissa Lara de Sousa Avelino Programa de Pós-Graduação em Nutrição e Saúde (PPGNS), Universidade Estadual do Ceará, Fortaleza, CE, Brasil https://orcid.org/0009-0007-5294-7027
José Artur Costa D’Almeida Hospital Geral de Fortaleza (HGF-SUS), Fortaleza, CE, Brasil. https://orcid.org/0000-0002-6627-6515
Maria Luisa Pereira de Melo Programa de Pós-Graduação em Nutrição e Saúde (PPGNS), Universidade Estadual do Ceará, Fortaleza, CE, Brasil https://orcid.org/0000-0002-3606-2217

DOI:

https://doi.org/10.52521/nutrivisa.v12i1.14552

Keywords:

multiple sclerosis; nutritional status; quality of life.

Abstract

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by inflammation, neurodegeneration, and can lead to physical disability, and cognitive impairment. The aim of the study was to analyze the nutritional status and quality of people live with MS, and observe whether there is an association between these factors. This is a cross-sectional study with a quantitative approach, with 110 patients undergoing outpatient treatment. A semi-structured questionnaire was applied to assess sociodemographic characteristics, lifestyle, clinical conditions, quality of life (Functional Assessment of Multiple Sclerosis Quality of Life Instrument, FAMS) and nutritional status (body mass index, BMI; waist circumference, WC; waist-to-hip ratio, WHR; and % body fat, %BF). The average age was 37.17 (10.60) years, the duration of illness was 6.28 (4.65) years, with a predominance of females, and level of disability (EDSS = 1.92). The group was overweight (BMI, 55.4%), high WC (51.8%), and high %BF, according to BIA (56.4%). Quality of life was significantly lower in malnourished patients (BMI, p = 0.009), in those with higher WC (p = 0.003), WHR (p = 0.020), and %BF (BIA, p = 0.002; US, p = 0.011). WC (p = 0.009), WHR (p = 0.003), and %BF obtained by BIA (p = 0.013) and US (p = 0.004) increased significantly with increasing EDSS. Therefore, it becomes essential to track these conditions in different MS treatment centers so that nutritional guidelines can be established.

References

ALBUQUERQUE, L. DA.S.; DAMASCENO, N.R.T.; MAIA, F. N.; CARVALHO, B. M. DE.; MAIA, C.S. C.; D'ALMEIDA, J. A. C.; MELO, M. L.P. Cardiovascular risk estimated in individuals with multiple sclerosis: a case-control study. Mult Scler Relat Disord. 2021, v. 54, p. 1-7. Doi: 10.1016/j.msard.2021.103133.

BARNES, C.L.K.; HAYWARD, C.; PORTEOUS, D.J.; CAMPBELL, H.; JOSHI P.K.; WILSON, J.F. Contribution of common risk variants to multiple sclerosis in Orkney and Shetland. Eur J Hum Genet, v.29, p.1701–1709, 2021. Doi: 10.1038/s41431-021-00914-w.

BIANCO, J., DAMASCENO, A., BECKER, J., CASARIN, F., CARLOS, N., MARTINS, T., YAZAWA, P. Prevalência da esclerose múltipla em pacientes tratados com medicamentos modificadores do curso da doença utilizando dados do Sistema Único de Saúde brasileiro. J Bras Econ Saúde, v. 15, n.1, p.12–23. 2023. Doi: 10.21115/JBES.

BRASIL. Conselho Nacional de Saúde. Resolução CNS no 466/2012 – Diretrizes e normas regulamentadoras de pesquisa envolvendo seres humanos. Diário Oficial da União. Brasília: CNS, 2012.

CARVALHO, B.M.; SILVA, R.S.C.; LIMA, V.V.M.; ALMONDES, K.G.S.; RODRIGUES, F.N.S.; D’ALMEIDA, J.A.C.; MELO, M.L.P. Excess weight increases the risk of sarcopenia in patients with multiple sclerosis. Mult Scler Relat Disord, v.79, p.105049, 2023. Doi: 10.1016/j.msard.2023.105049.

FANARA, S.; APRILE, M.; IACONO, S.; SCHIRÒ, G.; BIANCHI, A.; BRIGHINA, F.; DOMINGUEZ, L.J.; RAGONESE, P.; SALEMI, G. The role of nutritional lifestyle and physical activity in multiple sclerosis pathogenesis and management: a narrative review. Nutrients, v.13, n.11, p.3774, 2021. Doi: 10.3390/nu13113774.

FITZGERALD, K.C.; SALTER, A.; TYRY, T.; FOX, R.J.; CUTTER, G.; MARRIE, R.A. Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis. Mult Scler, v.26, n.8, p.976-986, 2020. Doi: 10.1177/1352458519845836.

GBD 2016, Multiple Sclerosis Collaborators. Global, Regional, and National Burden of Multiple Sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, v.18, n.3, p.269–285, 2019. Doi: 10.1016/S1474-4422.

GIANNOPAPAS, V.; STEFANOU, M.I.; SMYRNI, V.; KITSOS, D.K.; KOSMIDOU, M.; STASI, S.; GIANNOPOULOS, S. Waist circumference and body mass index as predictors of disability progression in multiple sclerosis: A Systematic Review and Meta-Analysis. J Clin Med, v.13, n.6, p.1739, 2024. Doi: 10.3390/jcm13061739.

HOGLUND, R.A.A.; MEYER, H.E.; STIGUM, H.; TORKILDSEN, O.; GRYTTEN, N.; HOLMOY, T.; NAKKEN, O. Association of body mass index in adolescence and young adulthood and long-term risk of multiple sclerosis: a population-based study. neurology. v.7, n.97, p.e2253-e2261, 2021. Doi: 10.1212/WNL.0000000000012957.

KURTZKE, J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, v.33, p.1444–1452, 1983. Doi: 10.1212/ wnl.33.11.1444.

LOHMAN, T.G.; HOUTKOOPER, L.; GOING, S.B. Body fat measurements go high-tech: not all are created equal. ACSMs Health Fit J, v.1, n.1, p.30-35, 1997.

LUTFULLIN, I.; EVESLAGE, M.; BITTNER, S.; ANTONY, G.; FLASKAMP, M.; LUESSI, F.; SALMEN, A.; GISEVIUS, B.; KLOTZ, L.; KORSUKEWITZ, C.; BERTHELE, A.; GROPPA, S.; THEN BERGH, F.; WILDEMANN, B.; BAYAS, A.; TUMANI, H.; MEUTH, S.G.; TREBST, C.; ZETTL, U.K.; PAUL, F.; HEESEN, C.; KUEMPFEL, T.; GOLD, R.; HEMMER, B.; ZIPP, F.; WIENDL, H.; LÜNEMANN, J.D. Association of obesity with disease outcome in multiple sclerosis. J Neurol Neurosurg Psychiatry, v.94, n.1, p.57-61, 2023. Doi: 10.1136/jnnp-2022-329685.

MARQUES, V.D.; PASSOS, G.R.; SENDES, M.F.; CALLEGARO, D.; LANA-PEIXOTO, M.A. Brazilian Consensus for The Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis. Arq Neuropsiquiatr, v. 76, n. 8, p. 539–554, 2018. Doi: 10.1590/0004-282X20180078.

MATUSIK, E.; DURMALA, J.; KSCIUK, B.; MATUSIK, P. Body composition in multiple sclerosis patients and its relationship to the disability level, disease duration and glucocorticoid therapy. Nutrients, v.14, n.20, p.4249, 2022. Doi: 10.3390/nu14204249.

MENDES, M.F.; BALSIMELLI, S.; STANGEHAUS G.; TILBERY C. P. Validação de escala de determinação funcional da qualidade de vida na esclerose múltipla para a língua portuguesa. Arq Neuropsiquiatr, v.62, n.1, p. 108-113, 2004. Doi: 10.1590/S0004-282X2004000100019.

MOGIŁKO, N.; MALGORZEWICZ, S. Prevalence of poor nutrition status in multiple sclerosis patients assessed by different diagnostic tools. Acta Biochim Pol, v.70, n.2, p.343-345, 2023. Doi:10.18388/abp.2020_6578.

OLEK, M.J. Multiple Sclerosis. Ann Intern Med, v.174, n.6, p.81-89, 2021. Doi: 10.7326/AITC202106150.

PÉREZ, C.A.; CUASCUT, F.X.; HUTTON, G.J. Immunopathogenesis, diagnosis, and treatment of multiple sclerosis: a clinical update. Neurol Clin, v.41, n.1, p.87-106, 2023. Doi: 10.1016/j.ncl.2022.05.004.

PIACENTINI, C.; ARGENTO, O.; NOCENTINI, U. Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions. Arq Neuropsiquiatr, v.81, n.6, p. 585-596, 2023. Doi:10.1055/s-0043-1763485.

PILUTTI, L. A.; MOTL, R.W. Body composition and disability in people with multiple sclerosis: a dual-energy x-ray absorptiometry study. Mult Scler Relat Disord, v. 29, p. 41-47. 2019. Doi: 10.1016/j.msard.2019.01.009.

SAFAEI, M.; SUNDARARAJAN, E.A.; DRISS, M.; BOULILA, W.; SHAPI’I, A. A systematic literature review on obesity: Understanding the causes and consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med, v.136, p.104754, 2021. Doi: 10.1016/j.compbiomed.2021.104754.

SCHREINER, T.G.; GENES, T.M. Obesity and multiple sclerosis: a multifaceted association. J Clin Med, v.10, n.12, p.2689, 2021. Doi:10.3390/jcm10122689.

TAYLOR, E.B. The complex role of adipokines in obesity, inflammation, and autoimmunity. Clin Sci, v. 135, n. 6, p. 731-752, 2021. Doi: 10.1042/cs20200895.

VESPASIANO, B.S.; DIAS, R.C.D.A. A utilização do Questionário Internacional de Atividade Física (IPAQ) como ferramenta diagnóstica do nível de aptidão física: uma revisão no Brasil. Saúde Rev, v.12, n.32, p.49-54, 2012. Doi: 10.15600/2238-1244/.

WALTON C, KING R, RECHTMAN L, KAYE W, LERAY E, MARRIE RA, ROBERTSON N, LA ROCCA N, UITDEHAAG B, VAN DER MEI I, WALLIN M, HELME A, ANGOOD NAPIER C, RIJKE N, BANEKE P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler, v. 26, n. 14, p. 816-1821. 2020. Doi: 10.1177/1352458520970841.

World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Geneva: World Health Organization. Report of WHO Consultation on Obesity. 1988.

World Health Organization (WHO). Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk. Geneva: World Health Organization. 2007.